About the authors |
|
ix | |
Acknowledgements |
|
xi | |
Statements of professional interest |
|
xii | |
Foreword |
|
xiii | |
Introduction |
|
xv | |
Part One: Essential Information |
|
1 | (32) |
|
|
3 | (12) |
|
|
3 | (5) |
|
|
3 | (4) |
|
1.1.2 Smoking consumption |
|
|
7 | (1) |
|
1.1.3 Exposure to environmental tobacco smoke |
|
|
7 | (1) |
|
1.1.4 Beliefs about smoking |
|
|
7 | (1) |
|
|
8 | (2) |
|
1.3 Sources for updating prevalence statistics |
|
|
10 | (1) |
|
1.4 Multiple choice questions |
|
|
10 | (5) |
|
2 The health risks of smoking and the benefits of stopping |
|
|
15 | (18) |
|
|
15 | (4) |
|
|
17 | (1) |
|
2.1.2 Cardiovascular disease |
|
|
17 | (1) |
|
2.1.3 Chronic obstructive pulmonary disease (COPD) |
|
|
18 | (1) |
|
2.1.4 Other life-threatening diseases |
|
|
18 | (1) |
|
|
19 | (4) |
|
2.2.1 Non-life-threatening physical diseases linked to smoking |
|
|
20 | (1) |
|
2.2.2 Smoking and mental health |
|
|
20 | (1) |
|
2.2.3 Reproductive health |
|
|
21 | (1) |
|
2.2.4 Environmental tobacco smoke |
|
|
22 | (1) |
|
2.3 Health benefits of smoking cessation |
|
|
23 | (3) |
|
|
24 | (1) |
|
2.3.2 Cardiovascular disease |
|
|
24 | (1) |
|
2.3.3 Chronic obstructive pulmonary disease (COPD) |
|
|
24 | (1) |
|
2.3.4 Other life-threatening diseases |
|
|
25 | (1) |
|
2.3.5 Smoking cessation and reproductive health |
|
|
25 | (1) |
|
2.3.6 Smoking cessation and mental health |
|
|
25 | (1) |
|
2.3.7 Morbidity and smoking cessation |
|
|
25 | (1) |
|
2.3.8 The protective effects of smoking |
|
|
26 | (1) |
|
2.4 Sources for updating health information and statistics |
|
|
26 | (1) |
|
2.5 Multiple choice questions |
|
|
26 | (7) |
Part Two: Practical Advice |
|
33 | (93) |
|
|
35 | (27) |
|
3.1 Assessment and recording of smoking status |
|
|
35 | (3) |
|
3.1.1 Asking about smoking status |
|
|
36 | (1) |
|
3.1.2 Recording smoking status |
|
|
37 | (1) |
|
3.2 Advising smokers to stop and assessing interest in quitting |
|
|
38 | (3) |
|
3.2.1 Advising clients to stop smoking |
|
|
38 | (2) |
|
3.2.2 Assessment of interest in quitting |
|
|
40 | (1) |
|
3.2.3 Recording advice given and responses |
|
|
41 | (1) |
|
|
41 | (2) |
|
3.3.1 Evidence of compensatory smoking |
|
|
41 | (1) |
|
|
42 | (1) |
|
3.4 Reasons why stopping smoking can be difficult |
|
|
43 | (6) |
|
3.4.1 Perceived benefits of smoking |
|
|
43 | (1) |
|
The special case of 'stress relief' |
|
|
43 | (1) |
|
3.4.2 Nicotine dependence |
|
|
44 | (3) |
|
3.4.3 Tobacco withdrawal syndrome |
|
|
47 | (2) |
|
The special case of anxiety |
|
|
48 | (1) |
|
3.5 Treatment to help with stopping smoking |
|
|
49 | (4) |
|
3.5.1 Principles of specialist treatment |
|
|
49 | (1) |
|
3.5.2 Types of medication |
|
|
49 | (3) |
|
Nicotine replacement therapy (NRT) |
|
|
50 | (1) |
|
|
51 | (1) |
|
3.5.3 Other treatments and interventions |
|
|
52 | (1) |
|
3.6 Referral to local services |
|
|
53 | (1) |
|
|
53 | (3) |
|
3.8 Multiple choice questions |
|
|
56 | (6) |
|
4 Intensive one-to-one support and advice |
|
|
62 | (46) |
|
4.1 Smoking cessation treatments and their outcome |
|
|
62 | (6) |
|
4.1.1 Evaluation of smoking cessation methods |
|
|
62 | (2) |
|
4.1.2 Short-term treatment outcomes |
|
|
64 | (1) |
|
4.1.3 Long-term treatment outcomes |
|
|
65 | (1) |
|
|
65 | (3) |
|
|
68 | (6) |
|
4.2.1 Nicotine dependence |
|
|
68 | (1) |
|
4.2.2 Interest in quitting and willingness to attend for treatment |
|
|
69 | (2) |
|
4.2.3 Smoking characteristics |
|
|
71 | (1) |
|
4.2.4 Carbon monoxide monitoring |
|
|
72 | (2) |
|
|
74 | (16) |
|
4.3.1 Nicotine replacement therapy (NRT) |
|
|
74 | (6) |
|
Nicotine transdermal patch |
|
|
75 | (1) |
|
|
76 | (1) |
|
|
76 | (1) |
|
|
77 | (1) |
|
Nicotine sublingual tablets |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
78 | (2) |
|
|
80 | (2) |
|
4.3.3 Explanation of medications |
|
|
82 | (1) |
|
4.3.4 Supplying medications |
|
|
83 | (4) |
|
4.3.5 Treatment points in special populations of smokers |
|
|
87 | (2) |
|
|
89 | (1) |
|
4.4 Behavioural support - withdrawal oriented treatment |
|
|
90 | (8) |
|
|
90 | (2) |
|
|
92 | (1) |
|
4.4.3 Urges to smoke and what to do about them |
|
|
93 | (2) |
|
|
95 | (1) |
|
4.4.5 End of treatment and relapse prevention |
|
|
96 | (2) |
|
|
98 | (2) |
|
4.5.1 National monitoring |
|
|
98 | (1) |
|
|
99 | (1) |
|
4.6 Multiple choice questions |
|
|
100 | (8) |
|
|
108 | (5) |
|
5.1 Recruiting smokers into treatment by telephone |
|
|
108 | (2) |
|
5.2 Behavioural support by telephone |
|
|
110 | (1) |
|
5.2.1 Telephone counselling |
|
|
110 | (1) |
|
5.2.2 Combined telephone and face-to-face counselling |
|
|
110 | (1) |
|
5.2.3 Telephone follow-ups to treatment |
|
|
111 | (1) |
|
5.3 Multiple choice questions |
|
|
111 | (2) |
|
|
113 | (13) |
|
6.1 Recruitment and assessment |
|
|
113 | (3) |
|
6.1.1 Recruiting for groups |
|
|
113 | (2) |
|
6.1.2 Assessing clients for group treatment |
|
|
115 | (1) |
|
6.1.3 Logistics of group treatment |
|
|
116 | (1) |
|
6.2 Treatment programme for groups |
|
|
116 | (1) |
|
6.3 Group treatment content |
|
|
117 | (6) |
|
|
117 | (2) |
|
|
119 | (2) |
|
|
121 | (1) |
|
6.3.4 End of treatment, relapse prevention and ongoing support |
|
|
122 | (1) |
|
6.4 Monitoring and follow-up |
|
|
123 | (1) |
|
|
123 | (1) |
|
6.5 Multiple choice questions |
|
|
123 | (3) |
Answers to multiple choice questions |
|
126 | (2) |
Appendix 1 Bupropion (Zyban) — special patient groups |
|
128 | (2) |
Appendix 2 Bupropion (Zyban) — drug interactions |
|
130 | (2) |
Appendix 3 Effect of tobacco abstinence on metabolism of some drugs |
|
132 | (2) |
Appendix 4 Resources |
|
134 | (4) |
Appendix 5 Examples of what to say when intervening with smoking clients |
|
138 | (8) |
Index |
|
146 | |